STOCK TITAN

Cvs Health (CVS) Stock News

CVS NYSE

Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.

CVS Health Corporation operates an integrated health care model that combines retail pharmacy, pharmacy benefit management, health insurance, medical clinics, specialty and mail pharmacy support, and related consumer health services. Recurring company news includes quarterly results and guidance, segment performance across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness, and capital returns through common-stock dividends.

Updates also cover CVS Caremark formulary decisions, biosimilar adoption, Aetna prior authorization and plan-administration initiatives, community health investments by the CVS Health Foundation, and developments involving Omnicare, the company's long-term care pharmacy subsidiary.

Rhea-AI Summary

CVS Health announced plans to start administering COVID-19 vaccines at five select locations in New Mexico beginning March 31, 2021. Appointments for vaccinations will open on March 30. Eligible recipients include individuals meeting state criteria, K-12 teachers, and childcare workers. The vaccines will be provided at no cost for insured patients and through a federal program for the uninsured. CVS plans to gradually expand vaccination access across more locations in New Mexico as supply increases, aiming to administer up to 25 million shots monthly across the country.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
covid-19
-
Rhea-AI Summary

CVS Health announced it will start administering COVID-19 vaccines on March 31 at select CVS Pharmacy locations in Washington. Appointments can be booked starting March 30, with vaccinations for individuals meeting state criteria, including K-12 teachers and childcare workers. The service is free for insured patients and uninsured individuals through a federal program. Initially, vaccines will be offered at select locations in Burien, Lakewood, and Seattle, with plans for expansion as vaccine supply increases.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
covid-19
-
Rhea-AI Summary

CVS Health (NYSE: CVS) announced plans to administer COVID-19 vaccines starting on March 31, 2021 at select locations in West Virginia. Appointments can be booked beginning March 30. Vaccinations will be available for individuals meeting state criteria, K-12 teachers, and childcare workers. CVS aims to enhance vaccine access, with no cost for insured patients. The initiative spans hundreds of locations nationwide, with a capacity to administer 20-25 million shots monthly as supply increases.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
covid-19
Rhea-AI Summary

CVS Health has launched COVID-19 antibody testing at nearly 60 MinuteClinic locations across Massachusetts, providing results in just 15 minutes. The service is intended to assess previous exposure to the virus and costs $38. This initiative is part of CVS Health's broader commitment to accessible COVID-19 testing, with over 15 million tests administered across more than 4,800 pharmacy locations nationwide. MinuteClinic aims to meet the growing demand for affordable testing by leveraging its convenient locations and extended hours.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.13%
Tags
covid-19
-
Rhea-AI Summary

CVS Health (NYSE: CVS) has announced the launch of COVID-19 antibody testing at over 100 MinuteClinic locations in Texas. This point-of-care test, which costs $38, provides results within 15 minutes, assessing prior exposure to the virus. MinuteClinic offers extended hours and may bill Medicaid for eligible patients. CVS Health has conducted more than 15 million COVID-19 tests nationwide and is exploring further service expansions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.13%
Tags
covid-19
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.48%
Tags
covid-19
Rhea-AI Summary

CVS Health announced the expansion of COVID-19 vaccinations in California, adding 119 pharmacy locations starting March 14, 2021. This increase brings the total number of participating CVS locations in the state to 286, contributing to the effort to combat the pandemic. Appointments can be booked from March 13, and the vaccines will be available to eligible individuals, including K-12 teachers and childcare workers. The vaccination supply is provided through the Federal Retail Pharmacy Program. CVS aims to administer 20-25 million doses per month across nearly 1,200 locations nationwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.48%
Tags
covid-19
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.48%
Tags
covid-19
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.48%
Tags
covid-19
Rhea-AI Summary

CVS Health will start administering COVID-19 vaccines at seven select locations in Illinois beginning on March 14, 2021. Appointments will open for booking on March 13. Eligible individuals include those meeting state criteria, K-12 teachers, and childcare workers. The vaccines are sourced via the Federal Retail Pharmacy Program. CVS aims to expand vaccination access as more supply becomes available, with a capacity to administer 20-25 million shots monthly across nearly 1,200 locations in 29 states and Puerto Rico.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.48%
Tags
covid-19

FAQ

What is the current stock price of Cvs Health (CVS)?

The current stock price of Cvs Health (CVS) is $98.315 as of June 19, 2026.

What is the market cap of Cvs Health (CVS)?

The market cap of Cvs Health (CVS) is approximately 125.4B.